{"id":22278,"date":"2023-01-31T09:39:29","date_gmt":"2023-01-31T17:39:29","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/?p=22278"},"modified":"2026-03-19T14:38:04","modified_gmt":"2026-03-19T21:38:04","slug":"what-is-inrebic-fedratinib","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/what-is-inrebic-fedratinib\/","title":{"rendered":"\u00bfQu\u00e9 es Inrebic (Fedratinib)?"},"content":{"rendered":"<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">Inrebic es un medicamento de prescripci\u00f3n antineopl\u00e1sico (usado para tratar el c\u00e1ncer) y tambi\u00e9n se conoce con el nombre gen\u00e9rico \u201c<\/span><span style=\"font-weight: 400;\">Fedratinib\u201d. Inrebic pertenece a una clase de medicamentos conocidos como JAK<\/span><span style=\"font-weight: 400;\">2 (Cinasa asociada a Janus 2)<\/span><span style=\"font-weight: 400;\"> inhibidores y fue aprobado por primera vez por la FDA en agosto de 2019. En entornos cl\u00ednicos, Inrebic est\u00e1 indicado para el tratamiento de la enfermedad primaria o secundaria de riesgo intermedio-2 o alto. <\/span><a href=\"https:\/\/www.mayoclinic.org\/diseases-conditions\/myelofibrosis\/symptoms-causes\/syc-20355057#:~:text=Myelofibrosis%20is%20an%20uncommon%20type,can%20cause%20weakness%20and%20fatigue.\"><span style=\"font-weight: 400;\">mielofibrosis<\/span><\/a><span style=\"font-weight: 400;\"> en adultos, as\u00ed como s\u00edntomas relacionados como esplenomegalia (agrandamiento del bazo).<\/span><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">La mielofibrosis es una forma cr\u00f3nica y rara de c\u00e1ncer de sangre en el que la m\u00e9dula \u00f3sea (los tejidos blandos y esponjosos dentro de los huesos grandes) se vuelve densa y fibrosa mediante un proceso llamado fibrosis.&nbsp;<\/span><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">Dado que la m\u00e9dula \u00f3sea es responsable de producir diversos componentes de la sangre (p. ej., gl\u00f3bulos rojos, gl\u00f3bulos blancos y plaquetas), la fibrosis interfiere con la producci\u00f3n normal de c\u00e9lulas sangu\u00edneas. Como resultado, se produce un exceso anormal de c\u00e9lulas sangu\u00edneas inmaduras. Debido a que la m\u00e9dula \u00f3sea no puede producir suficientes c\u00e9lulas sangu\u00edneas, el bazo asume parcialmente la producci\u00f3n de c\u00e9lulas sangu\u00edneas, lo que provoca una afecci\u00f3n llamada esplenomegalia (aumento del tama\u00f1o del bazo).&nbsp;<\/span><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">Inrebic viene en forma de c\u00e1psula oral.<\/span><\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_85 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Alternar tabla de contenido\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Palanca<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/what-is-inrebic-fedratinib\/#What_Is_Inrebic_Used_To_Treat\" >\u00bfPara qu\u00e9 se utiliza el Inrebic?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/what-is-inrebic-fedratinib\/#How_Does_Inrebic_Work\" >\u00bfC\u00f3mo funciona Inrebic?<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/what-is-inrebic-fedratinib\/#Mode_of_Action\" >Modo de acci\u00f3n<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/what-is-inrebic-fedratinib\/#Dosage_Form_and_Strength\" >Forma farmac\u00e9utica y concentraci\u00f3n<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/what-is-inrebic-fedratinib\/#Inrebic_Dosing_Information\" >Informaci\u00f3n de dosificaci\u00f3n de Inrebic<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/what-is-inrebic-fedratinib\/#What_To_Do_if_You_Miss_a_Dose\" >Qu\u00e9 hacer si se olvida una dosis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/what-is-inrebic-fedratinib\/#How_Is_Inrebic_Used\" >\u00bfC\u00f3mo se utiliza Inrebic?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/what-is-inrebic-fedratinib\/#Possible_Side_Effects_of_Inrebic\" >Posibles efectos secundarios de Inrebic<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/what-is-inrebic-fedratinib\/#Common_Side_Effects\" >Efectos secundarios comunes<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/what-is-inrebic-fedratinib\/#Less_Common_Side_Effects\" >Efectos secundarios menos comunes<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/what-is-inrebic-fedratinib\/#Rare_But_Severe_Side_Effects\" >Efectos secundarios raros pero graves<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/what-is-inrebic-fedratinib\/#Precaution_Recommendation\" >Precauciones y recomendaciones<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/what-is-inrebic-fedratinib\/#US_Boxed_Warning_Encephalopathy_Including_Wernicke\" >Advertencia en recuadro de EE. UU.: Encefalopat\u00eda, incluida la de Wernicke<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Is_Inrebic_Used_To_Treat\"><\/span>\u00bfPara qu\u00e9 se utiliza el Inrebic?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">Inrebic se utiliza como terapia dirigida para tratar tres tipos de mielofibrosis que incluyen:&nbsp;<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.leukaemia.org.au\/blood-cancer-information\/types-of-blood-cancer\/myeloproliferative-neoplasms\/primary-myelofibrosis\/#:~:text=What%20is%20Primary%20myelofibrosis%3F,to%20progressive%20bone%20marrow%20failure.\"><span style=\"font-weight: 400;\">Mielofibrosis primaria<\/span><\/a><span style=\"font-weight: 400;\"> (donde se desconoce la causa subyacente).<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Mielofibrosis post-policitemia vera (una enfermedad relacionada con la sobreproducci\u00f3n de gl\u00f3bulos rojos anormales por parte de la m\u00e9dula \u00f3sea).<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Mielofibrosis post trombocitemia esencial (enfermedad relacionada con la sobreproducci\u00f3n de plaquetas por la m\u00e9dula \u00f3sea).<\/span><\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">Como estas enfermedades son menos comunes, el Inrebic se considera un \u201cmedicamento hu\u00e9rfano\u201d.<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_Does_Inrebic_Work\"><\/span>\u00bfC\u00f3mo funciona Inrebic?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">En un individuo sano, la producci\u00f3n de c\u00e9lulas sangu\u00edneas est\u00e1 estrechamente regulada por <\/span><a href=\"https:\/\/medlineplus.gov\/genetics\/gene\/jak2\/\"><span style=\"font-weight: 400;\">JAK2<\/span><\/a><span style=\"font-weight: 400;\">, que es una enzima quinasa que promueve la producci\u00f3n, divisi\u00f3n y crecimiento de las c\u00e9lulas, entre las que se encuentran las c\u00e9lulas sangu\u00edneas de la m\u00e9dula \u00f3sea.&nbsp;<\/span><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">En el caso de pacientes con mielofibrosis, la enzima JAK2 se hiperactiva y provoca una producci\u00f3n anormal de c\u00e9lulas sangu\u00edneas inmaduras y, como resultado, el bazo se agranda significativamente.&nbsp;<\/span><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">Inrebic act\u00faa inhibiendo la enzima JAK2 para retardar el crecimiento anormal de las c\u00e9lulas sangu\u00edneas y aliviar los s\u00edntomas asociados con la mielofibrosis. Inrebic reduce el tama\u00f1o del bazo, el dolor \u00f3seo o muscular, la picaz\u00f3n, los sudores nocturnos, el dolor debajo de las costillas del lado izquierdo y el malestar gastrointestinal.<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Mode_of_Action\"><\/span>Modo de acci\u00f3n<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">Inrebic contiene una sustancia activa, <\/span><span style=\"font-weight: 400;\">fedratinib,<\/span><span style=\"font-weight: 400;\"> que act\u00faa como inhibidor de la quinasa y bloquea la actividad de la enzima JAK2.&nbsp;<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Dosage_Form_and_Strength\"><\/span>Forma farmac\u00e9utica y concentraci\u00f3n<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">Inrebic solo est\u00e1 disponible en forma de c\u00e1psula dura de 100 mg. <\/span><span style=\"font-weight: 400;\">Este medicamento s\u00f3lo puede obtenerse mediante receta m\u00e9dica.<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Inrebic_Dosing_Information\"><\/span>Informaci\u00f3n de dosificaci\u00f3n de Inrebic<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">La dosis recomendada de Inrebic para adultos es de 400 mg (cuatro c\u00e1psulas de 100 mg) una vez al d\u00eda en pacientes con un recuento de plaquetas basal mayor o igual a 50.000\/mm3.&nbsp;<\/span><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">Sin embargo, podr\u00eda ser necesario reducir la dosis de Inrebic si los pacientes presentan insuficiencia renal o toman otros medicamentos, como inhibidores potentes del CYP3A4. Estos ajustes de dosis deben ser realizados por el m\u00e9dico tratante.&nbsp;<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_To_Do_if_You_Miss_a_Dose\"><\/span>Qu\u00e9 hacer si se olvida una dosis<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">Evite tomar una dosis doble de Inrebic para compensar la dosis olvidada. Si olvid\u00f3 su dosis, om\u00edtala y tome la siguiente dosis programada seg\u00fan lo prescrito por su m\u00e9dico.&nbsp;<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_Is_Inrebic_Used\"><\/span>\u00bfC\u00f3mo se utiliza Inrebic?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">Las c\u00e1psulas de Inrebic se toman por v\u00eda oral y pueden tomarse con o sin alimentos. Sin embargo, si experimenta molestias estomacales, n\u00e1useas o v\u00f3mitos a causa del medicamento, tomar Inrebic con una comida rica en grasas puede ayudar a reducir la probabilidad de estos efectos secundarios.<\/span><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">Su m\u00e9dico puede recomendar otros medicamentos junto con Inrebic para prevenir v\u00f3mitos, diarrea o n\u00e1useas.&nbsp;<\/span><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">Las c\u00e1psulas de Inrebic deben tragarse tal cual, sin masticarlas ni triturarlas.&nbsp;<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Possible_Side_Effects_of_Inrebic\"><\/span>Posibles efectos secundarios de Inrebic<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Common_Side_Effects\"><\/span><img loading=\"lazy\" decoding=\"async\" class=\"alignright wp-image-22280 size-full\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/liver.jpg\" alt=\"liver with increased enzymes\" width=\"420\" height=\"280\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/liver.jpg 420w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/liver-300x200.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/liver-330x220.jpg 330w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/liver-86x57.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/liver-167x111.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/liver-280x187.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/liver-370x247.jpg 370w\" sizes=\"auto, (max-width: 420px) 100vw, 420px\" \/>Efectos secundarios comunes<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">V\u00f3mitos y n\u00e1useas<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Diarrea<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Anemia<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Recuento sangu\u00edneo bajo (gl\u00f3bulos rojos y blancos), que disminuye temporalmente al iniciar el tratamiento con Inrebic. Esta disminuci\u00f3n puede aumentar el riesgo de infecci\u00f3n, anemia o sangrado.&nbsp;<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Nivel bajo de plaquetas en la sangre<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Nivel bajo de sodio en la sangre<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Aumento de las enzimas hep\u00e1ticas (ALT y AST)<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">espasmos musculares<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Debilidad<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Aumento de la creatinina s\u00e9rica<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Indigesti\u00f3n<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Dolor de cabeza<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">P\u00e9rdida de apetito&nbsp;<\/span><\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">Estos son efectos secundarios muy comunes, temporales y bastante manejables. Por ejemplo, los v\u00f3mitos y las n\u00e1useas pueden aliviarse con medicamentos de venta libre. Siempre consulte con su m\u00e9dico antes de tomar cualquier medicamento nuevo.<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Less_Common_Side_Effects\"><\/span>Efectos secundarios menos comunes<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">Algunos efectos secundarios menos comunes que se informan en pacientes que reciben Inrebic incluyen:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">Fatiga<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Dolor de huesos<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Aumento de la enzima amilasa<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Dolor en los brazos y las piernas<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Infecci\u00f3n del tracto urinario<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Dolor en las extremidades<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">aumento de peso<\/span><\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Rare_But_Severe_Side_Effects\"><\/span>Efectos secundarios raros pero graves<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">Las reacciones adversas raras pero potencialmente graves (notificadas en menos del 11% de los pacientes que recibieron %) incluyen:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\"><a href=\"https:\/\/www.ninds.nih.gov\/health-information\/disorders\/encephalopathy\">Encefalopat\u00eda<\/a>, incluyendo la encefalopat\u00eda de Wernicke, una afecci\u00f3n neurol\u00f3gica causada por niveles bajos de vitamina B1 (tiamina). Los pacientes experimentan problemas de visi\u00f3n, confusi\u00f3n, deterioro de la memoria y dificultad para el movimiento muscular y la coordinaci\u00f3n.&nbsp;<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Trombosis (<\/span><span style=\"font-weight: 400;\">trombosis venosa profunda, embolia pulmonar y trombosis arterial), que ocurre en pacientes que reciben otros inhibidores de JAK para tratar<\/span> <span style=\"font-weight: 400;\">artritis reumatoide.<\/span><span style=\"font-weight: 400;\">&nbsp;<\/span><\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">Para evitar estas complicaciones, es muy recomendable controlar el nivel de vitamina B1 en el organismo del paciente (antes o durante el tratamiento con Inrebic).&nbsp;<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Precaution_Recommendation\"><\/span>Precauciones y recomendaciones<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">Las siguientes son algunas recomendaciones que los pacientes deben seguir antes o durante el tratamiento con Inrebic:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">No tome Inrebic si usted est\u00e1 <\/span><b>embarazada o planea quedar embarazada<\/b><span style=\"font-weight: 400;\">. Inrebic puede da\u00f1ar al feto ya que este medicamento se absorbe a trav\u00e9s de la piel y los pulmones.&nbsp;<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">No tome Inrebic si usted est\u00e1 <\/span><b>amamantando o planea amamantar<\/b><span style=\"font-weight: 400;\">Dado que se desconoce si este medicamento se secreta o no en la leche materna, se recomienda evitar la lactancia mientras se toma Inrebic.&nbsp;<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Evite Inrebic si es al\u00e9rgico a <\/span><span style=\"font-weight: 400;\">fedratinib (un componente activo de Inrebic) o cualquier otro elemento no activo de este medicamento.&nbsp;<\/span><\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">Aseg\u00farate de<\/span> <span style=\"font-weight: 400;\">Informe a su proveedor de atenci\u00f3n m\u00e9dica si:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">Tiene insuficiencia renal o <a href=\"https:\/\/ameripharmaspecialty.com\/es\/otras-afecciones-de-salud\/una-descripcion-general-de-la-artritis-reumatoide\/\">artritis reumatoide<\/a>.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Tiene enfermedad del h\u00edgado.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Tiene deficiencia de tiamina (vitamina B1).<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Est\u00e1 tomando suplementos, vitaminas u otros inhibidores de JAK.<\/span><\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"US_Boxed_Warning_Encephalopathy_Including_Wernicke\"><\/span><span style=\"font-weight: 400;\">Advertencia en recuadro de EE. UU.: Encefalopat\u00eda, incluida la de Wernicke<\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><span style=\"font-weight: 400;\">Se han presentado casos de encefalopat\u00eda grave y mortal, incluyendo la de Wernicke, en pacientes tratados con fedratinib. La encefalopat\u00eda de Wernicke es una emergencia neurol\u00f3gica. Eval\u00fae los niveles de tiamina en todos los pacientes antes de iniciar el tratamiento con fedratinib, peri\u00f3dicamente durante el tratamiento y seg\u00fan indicaci\u00f3n cl\u00ednica. No inicie el tratamiento con fedratinib en pacientes con deficiencia de tiamina; reponga la tiamina antes de iniciar el tratamiento. Si se sospecha encefalopat\u00eda, suspenda inmediatamente el tratamiento con fedratinib e inicie el tratamiento con tiamina parenteral. Monitoree hasta que los s\u00edntomas se resuelvan o mejoren y los niveles de tiamina se normalicen.<\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>Inrebic es un medicamento antineopl\u00e1sico (usado para tratar el c\u00e1ncer) de venta con receta, tambi\u00e9n conocido con el nombre gen\u00e9rico de &quot;Fedratinib&quot;. Inrebic pertenece a una clase de medicamentos conocidos como inhibidores de JAK2 (Janus Associated Kinase 2) y fue aprobado por primera vez por la FDA en agosto de 2019.<\/p>","protected":false},"author":19,"featured_media":22279,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":true,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[64],"tags":[24],"class_list":["post-22278","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-discontinued","tag-rafik-boctor"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>What Is Inrebic (Fedratinib)? - AmeriPharma\u00ae Specialty Care<\/title>\n<meta name=\"description\" content=\"Learn about Inrebic (Fedratinib). Topics include how Inrebic works, what it&#039;s used to treat, dosage information and side effects.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/es\/interrumpido\/what-is-inrebic-fedratinib\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"What Is Inrebic (Fedratinib)? - AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"og:description\" content=\"Learn about Inrebic (Fedratinib). Topics include how Inrebic works, what it&#039;s used to treat, dosage information and side effects.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/es\/interrumpido\/what-is-inrebic-fedratinib\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-31T17:39:29+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-19T21:38:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/Inrebic-Fedratinib.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Rafik Boctor, RPh\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Rafik Boctor, RPh\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/discontinued\\\/what-is-inrebic-fedratinib\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/discontinued\\\/what-is-inrebic-fedratinib\\\/\"},\"author\":{\"name\":\"Rafik Boctor, RPh\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/#\\\/schema\\\/person\\\/c21bfa71455c03b1365598550b1e09a0\"},\"headline\":\"What Is Inrebic (Fedratinib)?\",\"datePublished\":\"2023-01-31T17:39:29+00:00\",\"dateModified\":\"2026-03-19T21:38:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/discontinued\\\/what-is-inrebic-fedratinib\\\/\"},\"wordCount\":1064,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/discontinued\\\/what-is-inrebic-fedratinib\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/01\\\/Inrebic-Fedratinib.jpg\",\"keywords\":[\"Rafik Boctor\"],\"articleSection\":[\"Discontinued\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/discontinued\\\/what-is-inrebic-fedratinib\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/discontinued\\\/what-is-inrebic-fedratinib\\\/\",\"name\":\"What Is Inrebic (Fedratinib)? - AmeriPharma\u00ae Specialty Care\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/discontinued\\\/what-is-inrebic-fedratinib\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/discontinued\\\/what-is-inrebic-fedratinib\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/01\\\/Inrebic-Fedratinib.jpg\",\"datePublished\":\"2023-01-31T17:39:29+00:00\",\"dateModified\":\"2026-03-19T21:38:04+00:00\",\"description\":\"Learn about Inrebic (Fedratinib). Topics include how Inrebic works, what it's used to treat, dosage information and side effects.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/discontinued\\\/what-is-inrebic-fedratinib\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/discontinued\\\/what-is-inrebic-fedratinib\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/discontinued\\\/what-is-inrebic-fedratinib\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/01\\\/Inrebic-Fedratinib.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/01\\\/Inrebic-Fedratinib.jpg\",\"width\":1280,\"height\":853,\"caption\":\"Woman holding Inrebic (Fedratinib) capsule\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/discontinued\\\/what-is-inrebic-fedratinib\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"What Is Inrebic (Fedratinib)?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/#\\\/schema\\\/person\\\/c21bfa71455c03b1365598550b1e09a0\",\"name\":\"Rafik Boctor, RPh\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1e32400f0b4ec39922e1405c206687bef22e2479e692243c9fd1e07606bab1dc?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1e32400f0b4ec39922e1405c206687bef22e2479e692243c9fd1e07606bab1dc?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1e32400f0b4ec39922e1405c206687bef22e2479e692243c9fd1e07606bab1dc?s=96&d=mm&r=g\",\"caption\":\"Rafik Boctor, RPh\"},\"description\":\"Rafik Boctor, RPh was born and raised in Cairo, Egypt. He received his degree from the Faculty of Pharmacy, Helwan University in 2011. The most rewarding part of his job is making positive changes in patients' health and well-being on a daily basis. His areas of expertise include immunoglobulins, chemotherapy and biologics. In his free time, he enjoys playing guitar, singing, and Latin dancing.\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/author\\\/rafik\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u00bfQu\u00e9 es Inrebic (Fedratinib)? - Atenci\u00f3n especializada AmeriPharma\u00ae","description":"Aprenda sobre Inrebic (Fedratinib). Los temas incluyen c\u00f3mo funciona Inrebic, para qu\u00e9 se usa, informaci\u00f3n sobre la dosis y efectos secundarios.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/es\/interrumpido\/what-is-inrebic-fedratinib\/","og_locale":"es_MX","og_type":"article","og_title":"What Is Inrebic (Fedratinib)? - AmeriPharma\u00ae Specialty Care","og_description":"Learn about Inrebic (Fedratinib). Topics include how Inrebic works, what it's used to treat, dosage information and side effects.","og_url":"https:\/\/ameripharmaspecialty.com\/es\/interrumpido\/what-is-inrebic-fedratinib\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2023-01-31T17:39:29+00:00","article_modified_time":"2026-03-19T21:38:04+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/Inrebic-Fedratinib.jpg","type":"image\/jpeg"}],"author":"Rafik Boctor, RPh","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Rafik Boctor, RPh","Est. reading time":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/what-is-inrebic-fedratinib\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/what-is-inrebic-fedratinib\/"},"author":{"name":"Rafik Boctor, RPh","@id":"https:\/\/ameripharmaspecialty.com\/zh\/#\/schema\/person\/c21bfa71455c03b1365598550b1e09a0"},"headline":"What Is Inrebic (Fedratinib)?","datePublished":"2023-01-31T17:39:29+00:00","dateModified":"2026-03-19T21:38:04+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/what-is-inrebic-fedratinib\/"},"wordCount":1064,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/what-is-inrebic-fedratinib\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/Inrebic-Fedratinib.jpg","keywords":["Rafik Boctor"],"articleSection":["Discontinued"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/what-is-inrebic-fedratinib\/","url":"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/what-is-inrebic-fedratinib\/","name":"\u00bfQu\u00e9 es Inrebic (Fedratinib)? - Atenci\u00f3n especializada AmeriPharma\u00ae","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/what-is-inrebic-fedratinib\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/what-is-inrebic-fedratinib\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/Inrebic-Fedratinib.jpg","datePublished":"2023-01-31T17:39:29+00:00","dateModified":"2026-03-19T21:38:04+00:00","description":"Aprenda sobre Inrebic (Fedratinib). Los temas incluyen c\u00f3mo funciona Inrebic, para qu\u00e9 se usa, informaci\u00f3n sobre la dosis y efectos secundarios.","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/what-is-inrebic-fedratinib\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/es\/discontinued\/what-is-inrebic-fedratinib\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/what-is-inrebic-fedratinib\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/Inrebic-Fedratinib.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/Inrebic-Fedratinib.jpg","width":1280,"height":853,"caption":"Woman holding Inrebic (Fedratinib) capsule"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/what-is-inrebic-fedratinib\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/zh\/"},{"@type":"ListItem","position":2,"name":"What Is Inrebic (Fedratinib)?"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/zh\/#website","url":"https:\/\/ameripharmaspecialty.com\/zh\/","name":"Cuidado especializado AmeriPharma\u00ae","description":"Atenci\u00f3n especializada por AmeriPharma","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/zh\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/zh\/#organization","name":"Atenci\u00f3n especializada de Ameripharma","url":"https:\/\/ameripharmaspecialty.com\/zh\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/zh\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/zh\/#\/schema\/person\/c21bfa71455c03b1365598550b1e09a0","name":"Rafik Boctor, RPh","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/1e32400f0b4ec39922e1405c206687bef22e2479e692243c9fd1e07606bab1dc?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/1e32400f0b4ec39922e1405c206687bef22e2479e692243c9fd1e07606bab1dc?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1e32400f0b4ec39922e1405c206687bef22e2479e692243c9fd1e07606bab1dc?s=96&d=mm&r=g","caption":"Rafik Boctor, RPh"},"description":"Rafik Boctor, RPh, naci\u00f3 y creci\u00f3 en El Cairo, Egipto. Se gradu\u00f3 de la Facultad de Farmacia de la Universidad de Helwan en 2011. Lo m\u00e1s gratificante de su trabajo es generar cambios positivos en la salud y el bienestar de los pacientes a diario. Sus \u00e1reas de especializaci\u00f3n incluyen inmunoglobulinas, quimioterapia y f\u00e1rmacos biol\u00f3gicos. En su tiempo libre, disfruta tocando la guitarra, cantando y bailando latino.","url":"https:\/\/ameripharmaspecialty.com\/es\/author\/rafik\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/Inrebic-Fedratinib.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/Inrebic-Fedratinib-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/Inrebic-Fedratinib-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/Inrebic-Fedratinib-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/Inrebic-Fedratinib-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/Inrebic-Fedratinib.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/Inrebic-Fedratinib.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/Inrebic-Fedratinib.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/Inrebic-Fedratinib.jpg",600,400,false],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/Inrebic-Fedratinib-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/Inrebic-Fedratinib-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/Inrebic-Fedratinib-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/Inrebic-Fedratinib-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/Inrebic-Fedratinib-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/Inrebic-Fedratinib-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/Inrebic-Fedratinib-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/Inrebic-Fedratinib.jpg",1280,853,false]},"uagb_author_info":{"display_name":"Rafik Boctor, RPh","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/rafik\/"},"uagb_comment_info":0,"uagb_excerpt":"Inrebic is an antineoplastic (used to treat cancer) prescription medicine and is also known by the generic name \u201cFedratinib.\u201d Inrebic belongs to a class of medications known as JAK2 (Janus Associated Kinase 2) inhibitors and was first approved by the FDA in August 2019.","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/Inrebic-Fedratinib.jpg",1280,853,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/Inrebic-Fedratinib.jpg",1280,853,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/Inrebic-Fedratinib.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/Inrebic-Fedratinib-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/Inrebic-Fedratinib-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/Inrebic-Fedratinib-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/Inrebic-Fedratinib.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/Inrebic-Fedratinib.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/Inrebic-Fedratinib.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/Inrebic-Fedratinib.jpg",600,400,false],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/Inrebic-Fedratinib-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/Inrebic-Fedratinib-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/Inrebic-Fedratinib-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/Inrebic-Fedratinib-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/Inrebic-Fedratinib-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/Inrebic-Fedratinib-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/Inrebic-Fedratinib-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/01\/Inrebic-Fedratinib.jpg",1280,853,false]},"rttpg_author":{"display_name":"Rafik Boctor, RPh","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/rafik\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/es\/category\/discontinued\/\" rel=\"category tag\">Discontinued<\/a>","rttpg_excerpt":"Inrebic is an antineoplastic (used to treat cancer) prescription medicine and is also known by the generic name \u201cFedratinib.\u201d Inrebic belongs to a class of medications known as JAK2 (Janus Associated Kinase 2) inhibitors and was first approved by the FDA in August 2019.","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/22278","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/users\/19"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/comments?post=22278"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/22278\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media\/22279"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media?parent=22278"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/categories?post=22278"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/tags?post=22278"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}